PTCL’s are a heterogeneous collection of malignancies originating from CD4 and CD8 T-cells, however the role of immune checkpoints in the pathogenesis of PTCL is not well established. This evidence concerns the gene CD8A and mature T-cell and NK-cell non-Hodgkin lymphoma.